FindTrial
Sign In

Growth parameters in children with β thalassemia major

Evaluation Of Insulin like Growth Factors in children with β thalassemia major

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/01/017266
Enrollment
40
Registered
2019-01-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D561- Beta thalassemia

Interventions

Control Intervention1: NIL: NIL

Sponsors

Maulana Azad Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All children between 5 and 19 years of age with β Thalassemia Major attending the Pediatric department at Lok Nayak Hospital.

Exclusion criteria

Exclusion criteria: 1)children with history of chronic liver disease,chronic kidney disease,hypothyroidism. 2)known case of Rheumatoid arthritis,systemic lupus Erythematosus,Tuberculosis,Acquired Immuno Deficiency Syndrome.

Design outcomes

Primary

MeasureTime frame
Comparison of IGF-1and IGFBP-3 levels in children with Ã? thalassemia major and healthy controls aged 5-19 years.Timepoint: 1 year—

Secondary

MeasureTime frame
IGFs and their relationship with growth parameters in Ã? thalassemia major. Relationship between IGFs and hemoglobin, serum ferritin and thyroid hormones Timepoint: 1 year—

Countries

India

Contacts

Public ContactDr Nandha Kumar

Maulana Azad Medical College

yadav.sangita@hotmail.com9968604307

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026